期刊文献+

Hsa-mir-196b慢病毒表达载体的构建及鉴定

Construction of Lentiviral Vector for the Expression of Hsa-mir-196b
原文传递
导出
摘要 目的构建Hsa-mir-196b慢病毒表达载体并对其进行鉴定。方法以正常人外周血DNA为模板,PCR扩增得到目的基因。通过HpaⅠ/XhoⅠ双酶切及其后的连接将其插入Lentilox3.7(pLL-3.7)质粒中。PCR筛选阳性克隆,测序鉴定。用pLL-3.7-mir-196b、pCMV-VSV-G和pCMV-dR8.91三质粒系统共感染HEK-293FT细胞,包装生产慢病毒。将所得病毒悬液梯度稀释后感染HEK293FT细胞,以检测病毒滴度,并用实时定量PCR检测慢病毒感染后Hsa-mir-196b的表达变化。结果 PCR及测序结果证明成功构建了pLL-3.7-mir-196b重组质粒。所得慢病毒上清滴度为(7.2±1.1)×107TU/ml。感染慢病毒的239FT细胞中,Hsa-mir-196b的表达量相对于未感染细胞提高了约24倍。结论成功构建Hsa-mir-196b慢病毒表达载体。 Objective To construct a lentiviral vector for the expression of Hsa-mir-196b. Methods Hsamir-196b gene amplified from the peripheral blood DNA of healthy subjects was inserted into the Lentilox 3.7 (pLL-3.7) plasmid by double digestion with HpaⅠ / XhoⅠand subsequent ligation. Plasmids pLL-3.7-mir-196b,pCMV-VSV-G and pCMV-dR8.91 were co-transfected into HEK-293FT cells for packaging of the lentivirus. HEK293FT cells were then transduced with an appropriately diluted lentivirus supernatant for the titration of virus titer. Expression of Hsa-mir-196b was investigated using real-time PCR. Results Results from the PCR and DNA sequencing confirmed that the recombinant plasmid pLL-3.7-mir-196b was successfully constructed. The titer of supernatant was 7.2 ±1.1× 107 TU / ml. The expression level of Has-mir-196b in the lentivirus transduced HEK-293FT cells was increased by 24-fold. Conclusion Hsa-mir-196b expression lentiviral vector was successfully constructed.
出处 《热带医学杂志》 CAS 2010年第5期513-515,F0002,共4页 Journal of Tropical Medicine
基金 教育部科学技术研究重点项目(No.208100)
关键词 Hsa-mir-196b 慢病毒 肿瘤 Hsa-mir-196b lentiviral vector tumor
  • 相关文献

参考文献12

  • 1Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs [J]. Nat Rev Genet, 2007,8(2) :93-103.
  • 2Du T, Zamore PD. microPrimer: the biogenesis and function of microRNA [ J ]. Development, 2005,132 ( 21 ) : 4645-4652.
  • 3Nunez-Iglesias J, Liu CC, Morgan TE, et al. Joint genomewide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation [J]. PLoS One, 2010,5(2) :e8898.
  • 4Trang P, Weidhaas JB, Slack FJ. MicroRNAs as potential cancer therapeutics [ J ]. Oncogene, 2009,353 (27) : S52-S57.
  • 5Lui WO, Pourmand N, Patterson BK, et al. Patterns of known and novel small RNAs in human cervical cancer [J]. Cancer Res, 2007,67 ( 13 ) : 6031-6043.
  • 6Schotte D, Chau JC, Sylvester G, et al. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia [ J ]. Leukemia, 2009,23 (2) : 313-322.
  • 7Friedmann T, John R. Gene Transfer: Delivery and Expression of DNA and RNA [M]. NY, USA: Cold Spring Harbor Laboratory Press, 2007 : 4755.
  • 8Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA [ J ]. Science, 2004,304 (5670) : 594-596.
  • 9Zhang S. The role of aberrant transcription factor in the progression of chronic myeloid leukemia [J]. Leuk Lymphoma, 2008,49(8) : 1463-1469.
  • 10Kawasaki H, Taira K. MicroRNA-196 inhibits HOXB8 expression in myeloid differentiation of HL60 cells [Jl. Nucleic Acids Symp Ser ( Oxf ), 2004, (48) : 211-212.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部